- Messages
- 8
- Location
- Oakland & Santa Rosa, California
I found this forum via a Google Alert for GcMAF which interests me. It's potent, hard to find, expensive to purchase, and of uncertain quality. Since serum Nagalase levels seem an often useful way to measure effectiveness of GcMAF, even in short intervals, I'm interested in access to such tests as well.
Please assume that I know little for sure about either of these.
I am eager to learn about sources, expense, quality, effectiveness, side effects, safety, and so forth about both GcMAF and tests for serum Nagalase level. Accessible papers in academic journals are especially interesting to me. I intend to accumulate what I understand at http://CureCancerNow.WetPaint.com as I learn of it.
Please add what you know about any of this either here, where I'll be watching, or directly to me as DickKarpinski@gmail.com when you have the time and energy for such unfunded activity.
I found GcMAF from a report by Bill Sardi referencing clinical trials for both cancer and HIV conducted on young otherwise healthy patients in Japan by Dr.Nobuto Yamamoto and reported in peer reviewed journals which are available for free online. I learned that not everyone responds to GcMAF in a report months ago at http://GcMAF.eu and thought of a complementary method.
Dr. Zheng Cui at Wake Forest invented LIFT, Leukocyte InFusion Therapy which uses apheresis to extract white blood cells including neutrophils and macrophages from a healthy donor for infusion into a cancer patient. He found first a cancer resistant mouse and later people whose white blood cells attack and kill cancer cells in the summer. Vitamin D? Hmmm. GcMAF is made in humans from plentiful vitamin D binding protein, aka Gc.
If you have a patient whose macrophages are not activated by GcMAF, then perhaps you could find a suitable donor whose macrophages are already activated, 10 to 15 percent of us in the summer, or perhaps use GcMAF to activate them any time of year and then use LIFT to supply them to the patient.
Since most of main stream medicine is ignoring both GcMAF and LIFT, possibly because of the limited potential for vast profits, we may need unconventional means of gathering and validating the information. I believe that this can be done in the complete absence of multi-million dollar investments, if enough smart people contribute their own efforts to the cause of improving health care outcomes.
Do you agree? Will you explain your position or give your advice?
Would any of the doctors who are using these therapies write up their results or even consent to being interviewed about them for publication in this forum or elsewhere?
What am I forgetting to consider about bringing the benefits of GcMAF to clinics around the world?
Richard Karpinski, Nitpicker Extraordinaire
Please assume that I know little for sure about either of these.
I am eager to learn about sources, expense, quality, effectiveness, side effects, safety, and so forth about both GcMAF and tests for serum Nagalase level. Accessible papers in academic journals are especially interesting to me. I intend to accumulate what I understand at http://CureCancerNow.WetPaint.com as I learn of it.
Please add what you know about any of this either here, where I'll be watching, or directly to me as DickKarpinski@gmail.com when you have the time and energy for such unfunded activity.
I found GcMAF from a report by Bill Sardi referencing clinical trials for both cancer and HIV conducted on young otherwise healthy patients in Japan by Dr.Nobuto Yamamoto and reported in peer reviewed journals which are available for free online. I learned that not everyone responds to GcMAF in a report months ago at http://GcMAF.eu and thought of a complementary method.
Dr. Zheng Cui at Wake Forest invented LIFT, Leukocyte InFusion Therapy which uses apheresis to extract white blood cells including neutrophils and macrophages from a healthy donor for infusion into a cancer patient. He found first a cancer resistant mouse and later people whose white blood cells attack and kill cancer cells in the summer. Vitamin D? Hmmm. GcMAF is made in humans from plentiful vitamin D binding protein, aka Gc.
If you have a patient whose macrophages are not activated by GcMAF, then perhaps you could find a suitable donor whose macrophages are already activated, 10 to 15 percent of us in the summer, or perhaps use GcMAF to activate them any time of year and then use LIFT to supply them to the patient.
Since most of main stream medicine is ignoring both GcMAF and LIFT, possibly because of the limited potential for vast profits, we may need unconventional means of gathering and validating the information. I believe that this can be done in the complete absence of multi-million dollar investments, if enough smart people contribute their own efforts to the cause of improving health care outcomes.
Do you agree? Will you explain your position or give your advice?
Would any of the doctors who are using these therapies write up their results or even consent to being interviewed about them for publication in this forum or elsewhere?
What am I forgetting to consider about bringing the benefits of GcMAF to clinics around the world?
Richard Karpinski, Nitpicker Extraordinaire